EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology

Hafsah Deepa Tootla iD, Elizabeth Prentice iD, Clinton Moodley iD, Gert Marais iD, Nyasha Nyakutira, Kessendri Reddy, Colleen Bamford, Abraham Niehaus iD, Andrew Whitelaw, Adrian Brink iD, Members (collaborators) of the Cape Town Antimicrobial Stewardship Study Alliance (CT-ASSA)

JAC-Antimicrobial Resistance · 05.03.2024 · 6 (2)

DOI: 10.1093/jacamr/dlae051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 22.03.2024. Verfasst von Hafsah Deepa Tootla und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Microbiology, National Health Laboratory Service, Red Cross War Memorial Children's Hospital, Cape Town, South Africa. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer, National Research Foundation South Africa.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Carbapenem-resistant Enterobacterales (CRE) are a substantial problem in Cape Town. CRE epidemiology is largely unknown and mortality remains high.

Objectives

To describe and characterize the clinical and microbiological epidemiology of CRE within Cape Town hospitals to better inform therapy with regard to current and novel antibiotics, as well as improve antimicrobial stewardship (AMS), and infection prevention and control (IPC).

Methods

This prospective, multicentre study performed between 1 November 2020 and 30 November 2022, across three public and three private hospitals included hospitalized participants with CRE from clinical cultures. Participant demographics, clinical information and microbiology results were collected and analysed.

Results

Ninety percent of participants were from public hospitals. The age distribution ranged from 7 days to 88 years. Notable risk factors for CRE infection included recent exposure to antibiotics, medical devices and surgery. The most prevalent species was Klebsiella pneumoniae. However, a higher proportion of Serratia marcescens compared with previous reports was identified. The detected carbapenemases were blaOXA-48-like (80%) and blaNDM (11%). With the exception of amikacin (63%), tigecycline (65%), colistin (95%) and ceftazidime/avibactam (87%), susceptibility to antibiotics was low.

Conclusions

This study identified common risk factors for CRE infection and generated a description of carbapenemase enzymes, species distribution and antibiograms, enabling a better understanding of CRE epidemiology. This provides insights into transmission patterns and resistance determinants of CREs, beneficial to informing data-driven regional patient management, AMS and IPC strategies.

Autor:innen und Institutionen

  • Division of Medical Microbiology, National Health Laboratory Service, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
  • Division of Medical Microbiology, National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
  • Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Division of Medical Microbiology, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.
  • Division of Medical Microbiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Division of Medical Microbiology, Pathcare, Cape Town, South Africa.

ORCID-Profile: Hafsah Deepa Tootla, Elizabeth Prentice, Clinton Moodley, Gert Marais, Abraham Niehaus, Adrian Brink

Förderung

  • Pfizer
  • National Research Foundation South Africa

Zitieren

APA

Tootla, H. D., Prentice, E., Moodley, C., Marais, G., Nyakutira, N., Reddy, K., Bamford, C., Niehaus, A., Whitelaw, A., Brink, A., & Members (collaborators) of the Cape Town Antimicrobial Stewardship Study Alliance (CT-ASSA) (2024). Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology. JAC-Antimicrobial Resistance, 6(2). https://doi.org/10.1093/jacamr/dlae051

Vancouver

Tootla HD, Prentice E, Moodley C, Marais G, Nyakutira N, Reddy K, et al. Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology. JAC-Antimicrobial Resistance. 2024;6(2). doi:10.1093/jacamr/dlae051

BibTeX
@article{Tootla2024,
  author = {Tootla, Hafsah Deepa and Prentice, Elizabeth and Moodley, Clinton and Marais, Gert and Nyakutira, Nyasha and Reddy, Kessendri and Bamford, Colleen and Niehaus, Abraham and Whitelaw, Andrew and Brink, Adrian and Members (collaborators) of the Cape Town Antimicrobial Stewardship Study Alliance (CT-ASSA), Members (collaborators) of the Cape Town Antimicrobial Stewardship Study Alliance (CT-ASSA)},
  title = {Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology},
  journal = {JAC-Antimicrobial Resistance},
  year = {2024},
  volume = {6},
  number = {2},
  doi = {10.1093/jacamr/dlae051}
}
Kostenlos starten →